Comparative Study on Non-Operative Treatment Strategies for Chopart Fractures
This study aims to compare the effectiveness of different non-operative treatment strategies for Chopart fractures, with the primary focus on patient-reported outcomes measured using the European foot and ankle society score.
6 weeks cast immobilization
+ Rigide sole
Treatment Study
Summary
Study start date: October 1, 2026
Actual date on which the first participant was enrolled.This research study is about finding the best non-surgical treatment for Chopart fractures, a type of ankle injury. These fractures are becoming more common due to better detection methods. Currently, treatment options range from immobilizing the ankle for 6-8 weeks to more active rehabilitation. However, it's unclear which approach works best. The study is conducted at Hospital Cantonal Fribourg (HFR), where about 50 Chopart injuries are treated yearly. The hospital typically immobilizes the ankle for healing, but this can cause muscle weakness and stiffness. Newer research suggests that a more active treatment might yield better results, but it's uncertain if this leads to quicker recovery or increased pain and complications. The study's main goal is to compare these treatment strategies using patient feedback and objective gait analysis. Participants in this study will be randomly assigned to one of two treatment groups. The first group will have their ankle immobilized using a cast or a special boot for six weeks. This provides stable conditions for healing but may cause muscle weakness and stiffness. The second group will wear a rigid-sole shoe and bear weight as tolerated. This approach allows early movement, reducing muscle weakness and maintaining ankle mobility, but there may be concerns about pain and insufficient fracture stabilization. The study will measure patient-reported outcomes using a questionnaire that combines the European Foot and Ankle Society (EFAS) Score and the Short Form-12 health survey. It will also use objective gait analysis to assess recovery progress.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.70 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
Active ComparatorGroup II
Study Objectives
Primary Objectives
Secondary Objectives